Skip to main content

Table 1 Characteristics of included SLE patients and HCs

From: Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes

 

Fresh cells, serum and MPs

Frozen serum and MPs

SLE patients

20

28

 Age, median (range)

45 (22–64)

42 (22–69)

 Sex, number (%) of females

17 (85)

24 (86)

 Disease manifestations at study inclusion, number (%) of patients

  Renal disease

2 (10)

8 (29)

  Vasculitis

2 (10)

3 (11)

  Arthritis

2 (10)

3 (11)

  Interstitial lung disease

1 (5)

0 (0)

  Haemolysis

1 (5)

1 (4)

  Alopecia

3 (15)

1 (4)

  Rash

2 (10)

3 (11)

  Mucosal ulcers

3 (15)

3 (11)

  Leucopenia

1 (5)

1 (4)

  Serositis

0 (0)

1 (4)

  Thrombocytopenia

0 (0)

1 (4)

 SLEDAI, median (range)

4 (0–12)

5 (0–18)

HCs

10

11

 Age, median (range)

33.5 (25–63)

34 (24–54)

 Sex, number (%) of females

6 (60)

9 (82)

  1. HC healthy control, SLE systemic lupus erythematosus, SLEDAI Systemic Lupus Erythematosus Disease Activity Index